Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 28, 2023

SELL
$4.2 - $6.01 $336 - $480
-80 Reduced 41.03%
115 $0
Q4 2022

Jan 27, 2023

SELL
$4.45 - $6.17 $1,993 - $2,764
-448 Reduced 69.67%
195 $1,000
Q3 2022

Nov 08, 2022

SELL
$5.36 - $7.43 $53 - $74
-10 Reduced 1.53%
643 $4,000
Q2 2022

Aug 10, 2022

BUY
$3.55 - $6.27 $2,318 - $4,094
653 New
653 $4,000

About CTI BIOPHARMA CORP


  • Ticker CTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,385,000
  • Market Cap $1.04B
  • Description
  • CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...
More about CTIC
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.